IL161821A0 - Pharmaceutical compositions containing an aminoquinoline or a hydroxyquinoline derivative - Google Patents

Pharmaceutical compositions containing an aminoquinoline or a hydroxyquinoline derivative

Info

Publication number
IL161821A0
IL161821A0 IL16182102A IL16182102A IL161821A0 IL 161821 A0 IL161821 A0 IL 161821A0 IL 16182102 A IL16182102 A IL 16182102A IL 16182102 A IL16182102 A IL 16182102A IL 161821 A0 IL161821 A0 IL 161821A0
Authority
IL
Israel
Prior art keywords
aminoquinoline
pharmaceutical compositions
compositions containing
hydroxyquinoline derivative
hydroxyquinoline
Prior art date
Application number
IL16182102A
Other languages
English (en)
Original Assignee
Lauren Charous
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lauren Charous filed Critical Lauren Charous
Publication of IL161821A0 publication Critical patent/IL161821A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
IL16182102A 2001-11-09 2002-11-12 Pharmaceutical compositions containing an aminoquinoline or a hydroxyquinoline derivative IL161821A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34587201P 2001-11-09 2001-11-09
PCT/US2002/036309 WO2003039546A1 (en) 2001-11-09 2002-11-12 New uses for anti-malarial therapeutic agents

Publications (1)

Publication Number Publication Date
IL161821A0 true IL161821A0 (en) 2005-11-20

Family

ID=23356861

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16182102A IL161821A0 (en) 2001-11-09 2002-11-12 Pharmaceutical compositions containing an aminoquinoline or a hydroxyquinoline derivative

Country Status (10)

Country Link
US (1) US20040167162A1 (xx)
EP (1) EP1450803A4 (xx)
JP (1) JP2005512998A (xx)
CN (1) CN1289086C (xx)
AU (1) AU2002363443B2 (xx)
CA (1) CA2466338C (xx)
HK (1) HK1075619A1 (xx)
IL (1) IL161821A0 (xx)
MX (1) MXPA04004393A (xx)
WO (1) WO2003039546A1 (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7084157B2 (en) * 2002-05-17 2006-08-01 Rajeev Raut Ophthalmic pharmaceutical compositions and methods for treating ocular inflammation
WO2004085402A1 (en) * 2003-03-27 2004-10-07 Council Of Scientific And Industrial Research Ring-substituted 8-aminoqunoline derivates as antimalarial agents
US20070134596A1 (en) * 2005-12-08 2007-06-14 Adrian Lungu Photosensitive printing element having nanoparticles and method for preparing the printing element
CN101466380A (zh) * 2006-02-16 2009-06-24 麦克莱恩医院 治疗帕金森病的方法和组合物
KR101067443B1 (ko) * 2009-06-23 2011-09-27 여오영 하이드록시클로로퀸을 함유하는 치핵 치료를 위한 국소투여용 주사제 조성물
CN103027915A (zh) * 2011-09-29 2013-04-10 中国医学科学院基础医学研究所 氯喹治疗和氯丙嗪预防肺感染和损伤的用途
CN103705516B (zh) * 2013-12-11 2016-01-06 武汉威立得生物医药有限公司 氯喔星在制备治疗或预防流感病毒感染的药物中的应用
KR101828553B1 (ko) * 2016-04-15 2018-02-13 한국화학연구원 신규한 벤조싸이오펜 유도체, 이의 약학적으로 허용 가능한 염 또는 이의 광학 이성질체, 이의 제조방법 및 이를 유효성분으로 함유하는 바이러스성 질환의 예방 또는 치료용 약학적 조성물
ES2844927T3 (es) 2016-06-28 2021-07-23 Hopitaux Paris Assist Publique Derivados de primaquina para la utilización en la prevención y/o el tratamiento de trastornos asociados al virus herpes gamma
CN111658648A (zh) * 2020-02-03 2020-09-15 中国人民解放军军事科学院军事医学研究院 4-氨基喹啉类化合物在治疗冠状病毒感染方面的应用
US20210244705A1 (en) * 2020-02-07 2021-08-12 Centre For Digestive Diseases Therapeutic compositions, products of manufacture and methods for ameliorating or preventing coronavirus infection
CN114908062B (zh) * 2020-02-16 2023-10-20 北京化工大学 盐酸甲氟喹或甲氟喹在制备治疗冠状病毒感染性疾病的药物的用途
US11007187B1 (en) * 2020-03-25 2021-05-18 Therapeutica Borealis Oy Medicine for Covid-19 and treatment
WO2021191496A1 (en) * 2020-03-25 2021-09-30 Therapeutica Borealis Oy Medicine for covid-19 and treatment
US11638722B2 (en) 2020-03-25 2023-05-02 Therapeutica Borealis Oy C/O Avance Attorneys Ltd. Medicine for Covid-19 and treatment
US11278602B2 (en) 2020-03-25 2022-03-22 Therapeutica Borealis Oy Medicine for Covid-19 and treatment
WO2021204717A1 (en) * 2020-04-06 2021-10-14 Oxandia Ltd Aminoquinolines for treating coronavirus infections
EP3892275A1 (en) * 2020-04-08 2021-10-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Aerosolization of hcq or its metabolites for the treatment of lung infections
CA3176360A1 (en) * 2020-04-21 2021-10-28 Noam Cohen Quinine and its use to generate innate immune response
CA3180854A1 (en) * 2020-04-24 2021-10-28 Thomas Julius Borody Products of manufacture and methods for treating, ameliorating or preventing microbial infections
US20230165851A1 (en) * 2020-04-27 2023-06-01 Immunologik Gmbh 6'-methoxycinchonan-9-ols for the treatment of coronaviral infections
CN115515935A (zh) * 2020-04-30 2022-12-23 中美华世通生物医药科技(武汉)股份有限公司 冠状病毒感染的治疗或预防
AU2021339013A1 (en) * 2020-09-14 2023-04-06 Philip Morris Products S.A. Pharmaceutical composition comprising hydroxychloroquine and uses thereof
DE102021000717A1 (de) * 2021-02-12 2022-08-18 Forschungszentrum Jülich GmbH Quinacrin als lnhibitor viraler Cysteinproteasen und/oder Serinproteasen
WO2023023651A1 (en) * 2021-08-19 2023-02-23 Arizona Board Of Regents On Behalf Of The University Of Arizona Quinacrine and derivatives thereof for treatment of viral infections
CN115869311A (zh) * 2022-12-30 2023-03-31 湖北工业大学 MefloquineHydrochloride在制备抗腺病毒ADV7药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4181725A (en) * 1977-05-02 1980-01-01 The Regents Of The University Of Michigan Method for alleviating psoriasis
US4496549A (en) * 1983-01-17 1985-01-29 American Cyanamid Company Treatment of malaria with antibiotics
US5153202A (en) * 1988-06-30 1992-10-06 Davis Michael H Method of inhibiting the activity of human immuno deficiency virus (HIV) in vivo
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
US5827681A (en) * 1996-12-20 1998-10-27 University Technology Corporation Rapid detection and drug sensitivity of malaria
US6572858B1 (en) * 1999-04-30 2003-06-03 Apt Pharmaceuticals, Llc Uses for anti-malarial therapeutic agents

Also Published As

Publication number Publication date
HK1075619A1 (en) 2005-12-23
CA2466338A1 (en) 2003-05-15
CA2466338C (en) 2010-01-12
AU2002363443B2 (en) 2006-02-16
MXPA04004393A (es) 2005-09-12
WO2003039546A1 (en) 2003-05-15
CN1612735A (zh) 2005-05-04
EP1450803A4 (en) 2008-09-03
EP1450803A1 (en) 2004-09-01
CN1289086C (zh) 2006-12-13
US20040167162A1 (en) 2004-08-26
JP2005512998A (ja) 2005-05-12

Similar Documents

Publication Publication Date Title
IL161821A0 (en) Pharmaceutical compositions containing an aminoquinoline or a hydroxyquinoline derivative
HK1072200A1 (en) Pro-micelle pharmaceutical compositions
HK1061810A1 (en) Tetrahydroquinoline derivatives
HUP0303325A3 (en) Pharmaceutical salts and pharmaceutical compositions containing them
EP1448187A4 (en) COMPOUNDS DERIVED FROM A NUCLEUS AMINE NUCLEUS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
IL161616A0 (en) Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
GB0111597D0 (en) Pharmaceutical compositions
IL158044A0 (en) Cyclopropylindole derivatives and pharmaceutical compositions containing the same
HUP0700124A2 (en) Quinoline compound
IL158300A0 (en) Bisarylimidazol derivatives and pharmaceutical compositions containing the same
HUP0401333A3 (en) Spiropyrazole compounds and pharmaceutical compositions containing them
IL156812A0 (en) Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
AU2002341205A1 (en) Pharmaceutical compositions comprising cyclosporin
IL157850A0 (en) Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same
GB0108099D0 (en) Aminopiperidine derivatives
AU2002253219A1 (en) Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same
IL160375A0 (en) Pharmaceutical compositions comprising lumiracoxib
AU2002347336A1 (en) Quinoline derivatives
IL161306A0 (en) Pharmaceutical formulation comprising (r)-bicalutamide
GB0104422D0 (en) Quinoline derivative
HK1068277A1 (en) Pharmaceutical compositions comprising chelidonineor derivatives thereof
IL148106A0 (en) Pharmaceutical compositions comprising 4-quinolones
GB0101239D0 (en) Medicinal aerosols
GB0104752D0 (en) Pharmaceutical compositions
HUP0402600A3 (en) D-proline derivatives and pharmaceutical compositions containing them